AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ATE.TO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Antibe Therapeutics Inc. stock price ended at $0.295 on Friday, after losing 0%.
(Updated on May 17, 2024)

Hold candidate since Apr 10, 2024 PDF

No changes to the price of Antibe Therapeutics Inc. stock on the last trading day (Friday, 17th May 2024). During the last trading day the stock fluctuated 0% from a day low at $0.295 to a day high of $0.295. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ATE.TO Signals & Forecast

The Antibe Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.295 and $0.291. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 16, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Antibe Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.265 and $0.260. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $0.260 may give a huge drop in the stock price.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $0.283 (-4.00%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (ATE.TO) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Antibe Therapeutics Inc. to open at $0.295, and during the day (based on 14 day Average True Range), to move between $0.285 and $0.305, which gives a possible trading interval of +/-$0.0095 (+/-3.22%) up or down from last closing price. If Antibe Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 6.45% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $0.265, some $0.0300 (10.17%) from the current price of $0.295, our system finds the risk reward attractive.

Is Antibe Therapeutics Inc. stock A Buy?

Antibe Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Antibe Therapeutics Inc. of Tuesday, May 21, 2024

Fair opening price May 21, 2024 Current price
$0.295 ( 0%) $0.295

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ATE.TO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.295 .
R2 0.295 .
R1 0.295 .
Current price: 0.295
Support S1 0.295 .
S2 0.295 .
S3 0.295 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 0.295
Support S1 0.265 -10.17%
S2 0.260 -11.86%
S3 0 .

FAQ

What is the symbol for Antibe Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Antibe Therapeutics Inc. is ATE.TO and it is traded on the TSX (Toronto Stock Exchange).

Should I buy or sell Antibe Therapeutics Inc. Stock?
Antibe Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Antibe Therapeutics Inc. Stock?
Antibe Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Antibe Therapeutics Inc. Stock.

What's the current price of Antibe Therapeutics Inc. Stock?
As of the end of day on the May 17, 2024, the price of an Antibe Therapeutics Inc. (ATE.TO) share was $0.295.

What is the 52-week high and low for Antibe Therapeutics Inc. Stock?
The 52-week high for Antibe Therapeutics Inc. Stock is $1.23 and the 52-week low is $0.150.

What is the market capitalization of Antibe Therapeutics Inc. Stock?
As of the May 17, 2024, the market capitalization of Antibe Therapeutics Inc. is 15.532M.

When is the next earnings date for Antibe Therapeutics Inc.?
The upcoming earnings date for Antibe Therapeutics Inc. is Jun 27, 2024.
Click to get the best stock tips daily for free!

About Antibe Therapeutics Inc.

Antibe Therapeutics. Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. Its lead compound is Otenaproxesul, a hydrogen sulfide-releasing derivative of napro... ATE.TO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT